Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, June 8, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
Novartis Pluvictoâ„¢ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
admin
-
June 4, 2025
Latest Pharma-News
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
admin
-
June 4, 2025
Latest Pharma-News
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
admin
-
April 11, 2025
Latest Pharma-News
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
admin
-
April 9, 2025
Latest Pharma-News
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
admin
-
April 9, 2025
Latest Pharma-News
Accumen’s 3DR Labs Partners with Resonance Health to develop its MRI Analysis Services
admin
-
February 5, 2020
0
Latest Pharma-News
US FDA Takes Significant Step in Coronavirus Response Efforts, Issues Emergency Use Centers for the Disease Control and Prevention’s (CDC) 2019-nCoV Real-Time RT-PCR Diagnostic...
admin
-
February 5, 2020
0
Latest Pharma-News
FDA approves Life-changer for all childrens with peanut allergies
admin
-
February 1, 2020
0
Latest Pharma-News
WuXi Biologics gives Operation Update Related to the Coronavirus Outbreak
admin
-
February 1, 2020
0
Latest Pharma-News
FDA Continues tough Support of Innovation in the Development of Gene Therapy Products
admin
-
January 30, 2020
0
Latest Pharma-News
Clozaril, Fazaclo ODT, Versacloz (clozapine): Drug Safety Communication – FDA reinforce Warning That Untreated Constipation Can Lead to Serious Bowel Problems
admin
-
January 29, 2020
0
Latest Pharma-News
Phase II DESTINY-Gastric01 trial of Enhertu (trastuzumab deruxtecan) versus chemotherapy met primary endpoint
admin
-
January 29, 2020
0
Latest Pharma-News
AstraZeneca’s Brilinta met primary endpoint in Phase III THALES trial in stroke
admin
-
January 29, 2020
0
Latest Pharma-News
FDA accepts for priority review Sanofi’s Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis
admin
-
January 28, 2020
0
Latest Pharma-News
AstraZeneca divests rights to Inderal, Tenormin, Tenoretic, Zestril and Zestoretic to Atnahs Pharma (Atnahs) to established hypertension medicines
admin
-
January 28, 2020
0
Latest Pharma-News
Medtronic Launches Efficio™ Software to facilitate Clinicians Efficiently Manage Targeted Drug Delivery Therapy with SynchroMed™ II
admin
-
January 27, 2020
1
Latest Pharma-News
FDA approves Tazverik (tazemetostat) for the treatment of adults and pediatric patients with metastatic or locally advanced epithelioid sarcoma
admin
-
January 27, 2020
0
1
...
131
132
133
...
145
Page 132 of 145
- Advertisment -
Most Read
Novartis Pluvictoâ„¢ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
June 4, 2025
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
June 4, 2025
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025